Previous Section Index Home Page

4 Oct 2004 : Column 1992W—continued

Osteoporosis

Sue Doughty: To ask the Secretary of State for Health how many DEXA scanners are available in the NHS; what plans he has to increase the numbers of DEXA scanners; and if he will make a statement. [188181]

Dr. Ladyman: This information is not collected centrally. Work is currently under way to rectify this.

Dexa scanners are now referred to as DXA scanners as this is the internationally accepted terminology.

Patient and Public Health Forums

Peter Bottomley: To ask the Secretary of State for Health what the budget of each intermediate body promoting patient and public health forums is. [188240]

Ms Rosie Winterton: The Commission for Patient and Public Involvement in Health has contracted for forum support services but cannot reveal the levels of individual contracts for reasons of commercial confidentiality. Exemption 13 (third party's commercial confidences) of the Open Government Code of Practice on Access to Government Information applies.

The total figure for forum support organisation contracts is £16.4 million; this is divided between 140 contracts.
 
4 Oct 2004 : Column 1993W
 

Pontefract General Infirmary

Mr. Bill O'Brien: To ask the Secretary of State for Health how many beds there were at the Pontefract General Infirmary in each of the past five years. [188829]


 
4 Oct 2004 : Column 1994W
 

Miss Melanie Johnson: The requested information is not validated centrally in the requested format. However, information for the relevant national health service trusts is shown in the tables.
Mid Yorkshire Hospitals NHS Trust—average daily number of available beds, by sector, 1996–97 to 2002–03

All specialties
(excluding day only)
General and acuteAcuteGeriatricMental illnessLearning disabilityMaternityDay only
1996–97
1997–98
1998–99
1999–2000
2000–01
2001–02
2002–031,5091,3991,1712280011093

Pinderfields and Pontefract Hospitals NHS Trust—verage daily number of available beds, by sector, 1996–97 to 2002–03

All specialties
(excluding day only)
General and acuteAcuteGeriatricMental illnessLearning disabilityMaternityDay only
1996–97000000058
1997–981,0851,023906118006236
1998–991,0641,001898104006358
1999–20001,050987885103006358
2000–011,0631,0008971046361
2001–021,0631,006903103005761
2002–03

Dewsbury Healthcare NHS Trust—average daily number of available beds, by sector, 1996–97 to 2002–03

All specialties (excluding day only)General and acuteAcuteGeriatricMental illnessLearning disabilityMaternityDay only
1996–97514398314857473531
1996–97514398314857473531
1997–98507389299907773520
1998–995093932921017263830
1999–20005214062921146764130
2000–015234082851246674133
2001–025314172811356784034
2002–03




Source:
Department of Health form KH03.




Primary Care Centres

Mr. Burstow: To ask the Secretary of State for Health what progress has been made towards meeting the target for new one stop primary care centres by December 2004. [187864]

Mr. Hutton: Good progress is being made, with more than 300 centres reported as being open, with many more in the course of development.

Prostate Cancer

Ross Cranston: To ask the Secretary of State for Health (1) what assessment he has made of the Prostate Cancer Risk Management Programme; [189565]

(2) what plans he has to raise public awareness of prostate cancer; [189567]

(3) what plans he has to raise awareness of prostate cancer among (a) general practitioners and (b) other health professionals; [189568]

(4) what progress has been made in tackling prostate cancer since 2000. [189570]

Miss Melanie Johnson: Good progress has been made since the national health service prostate cancer programme was launched on 6 September 2000, setting out the Government's approach to improving prostate cancer services in England and Wales.

As part of the prostate cancer risk management programme (PCRMP), evidence-based primary care resource packs were sent to all general practitioners in England on 23 September 2002 to aid them in understanding prostate cancer and counselling men (who are worried about prostate cancer, ensuring the men make an informed choice about whether or not to have a prostate specific antigen (PSA) test.

The Cancer Research UK primary care education research group is now in the process of evaluating the use of the packs. This evaluation includes:


 
4 Oct 2004 : Column 1995W
 

The evaluation is being jointly funded by the Department via national health service cancer screening programmes and Cancer Research UK and results are expected over the next year. The results of the evaluation will inform future revisions of the pack.

Other elements of the PCRMP include ensuring that a systematic and standardised follow-up pathway is available for individuals whose test result is above the PSA threshold and action to improve the quality of laboratory testing of PSA samples. Recommendations from the scientific reference group, which supports the PCRMP, were sent to all pathologists and urologists, along with a copy of the resource pack, in September 2002.

Other good progress has been made on prostate cancer. In 2003–04, the Department met its target of directly funding 4.2 million of research a year on prostate cancer. This is a twenty-fold increase compared with 1999–2000.

98.8 per cent., of patients with suspected urological cancers, including prostate, were seen for their first out-patient appointment within two weeks of urgent general practitioner referral between January and March 2004.

The cancer services collaborative is modernising cancer care, including prostate cancer, by reducing unnecessary delays in the system for patients throughout the cancer-journey.

There has been a 47 per cent., increase in the number of consultant urologists since 1997, from 343 to 503.

The National Institute for Clinical Excellence published guidance on improving outcomes in urological cancers in September 2002.

In response to the launch of the prostate cancer charter for action, we have set up the prostate cancer advisory group (PCAG) to facilitate collaboration between the Department of Health, the voluntary sector, and patient and professional groups. The PCAG is taking forward work in four main areas:

Regarding public awareness, we want men to be aware of their bodies and know what their prostate gland does, and also what can go wrong with it. We need to raise awareness in a responsible way and not scare men into rushing to see their general practitioners when there may be nothing wrong with them. The public awareness working group of PCAG has been reviewing information for men about prostate cancer, along with assessing the evidence over public awareness
 
4 Oct 2004 : Column 1996W
 
interventions, and will be making recommendations on the way forward for men and the national health service in England shortly.

The Department is funding other work on the public awareness of prostate cancer—a Section 64 grant to the Prostate Cancer Charity to increase further information about prostate cancer; a Section 64 grant to the Prostate Cancer Charity to improve the awareness of the risks and symptoms of prostate cancer among men from African and Afro-Caribbean communities in Britain; and DIPEx—the Database of Individual Patient Experiences website on prostate cancer.


Next Section Index Home Page